Literature DB >> 15221066

[Attention deficit hyperactivity disorder in adults. An overview].

E Sobanski1, B Alm.   

Abstract

Attention deficit hyperactivity disorder (ADHD), which is characterized by the inability to appropriately modulate attention and/or impulse control and hyperactivity, resulting in social, academic and occupational underachievement, is presently the topic of intensive discussion in German psychiatry. With a prevalence of 3-5%, ADHD is one of the most frequently seen disorders in child and adolescent psychiatry. With nearly 50% of childhood patients also affected during adulthood, this disorder is of much higher clinical significance for psychiatry than presumed thus far. The present review discusses current results of epidemiology, etiology, clinical symptoms and comorbidity, diagnostic assessment, pharmacotherapy, and psychological interventions for adults with ADHD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15221066     DOI: 10.1007/s00115-004-1757-9

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  74 in total

1.  Cerebellum in attention-deficit hyperactivity disorder: a morphometric MRI study.

Authors:  P C Berquin; J N Giedd; L K Jacobsen; S D Hamburger; A L Krain; J L Rapoport; F X Castellanos
Journal:  Neurology       Date:  1998-04       Impact factor: 9.910

2.  Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder.

Authors:  R A Barkley; J Biederman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-09       Impact factor: 8.829

Review 3.  Comorbidity in adults with attention-deficit/hyperactivity disorder.

Authors:  D J Marks; J H Newcorn; J M Halperin
Journal:  Ann N Y Acad Sci       Date:  2001-06       Impact factor: 5.691

4.  Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI.

Authors:  K Rubia; S Overmeyer; E Taylor; M Brammer; S C Williams; A Simmons; E T Bullmore
Journal:  Am J Psychiatry       Date:  1999-06       Impact factor: 18.112

5.  Venlafaxine versus stimulant therapy in patients with dual diagnosis ADD and depression.

Authors:  Mady Hornig-Rohan; Jay D Amsterdam
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2002-04       Impact factor: 5.067

6.  Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study.

Authors:  P Rasmussen; C Gillberg
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-11       Impact factor: 8.829

7.  Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop.

Authors:  G Bush; J A Frazier; S L Rauch; L J Seidman; P J Whalen; M A Jenike; B R Rosen; J Biederman
Journal:  Biol Psychiatry       Date:  1999-06-15       Impact factor: 13.382

8.  A cognitive remediation programme for adults with Attention Deficit Hyperactivity Disorder.

Authors:  Caroline S Stevenson; Stephanie Whitmont; Laurel Bornholt; David Livesey; Richard J Stevenson
Journal:  Aust N Z J Psychiatry       Date:  2002-10       Impact factor: 5.744

9.  Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status.

Authors:  S Mannuzza; R G Klein; A Bessler; P Malloy; M LaPadula
Journal:  Arch Gen Psychiatry       Date:  1993-07

10.  Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies.

Authors:  David Michelson; Lenard Adler; Thomas Spencer; Frederick W Reimherr; Scott A West; Albert J Allen; Douglas Kelsey; Joachim Wernicke; Anthony Dietrich; Denái Milton
Journal:  Biol Psychiatry       Date:  2003-01-15       Impact factor: 13.382

View more
  8 in total

Review 1.  Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD).

Authors:  Esther Sobanski
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-09       Impact factor: 5.270

Review 2.  [The health economics of attention deficit hyperactivity disorder in Germany. Part 1: Health care utilization and cost of illness].

Authors:  M Schlander; G-E Trott; O Schwarz
Journal:  Nervenarzt       Date:  2010-03       Impact factor: 1.214

3.  Emotion perception in adult attention-deficit hyperactivity disorder.

Authors:  Jeanne Bisch; Benjamin Kreifelts; Johannes Bretscher; Dirk Wildgruber; Andreas Fallgatter; Thomas Ethofer
Journal:  J Neural Transm (Vienna)       Date:  2016-02-05       Impact factor: 3.575

4.  [Attention deficit-hyperactivity disorder (ADHD) and comorbid mental disorders : ADHD-specific self-rating scales in differential diagnostics].

Authors:  M Paucke; T Stark; C Exner; C Kallweit; U Hegerl; M Strauß
Journal:  Nervenarzt       Date:  2018-11       Impact factor: 1.214

5.  Attention deficit hyperactivity disorder in adulthood: diagnosis, etiology and therapy.

Authors:  Alexandra Philipsen; Bernd Hesslinger; Ludger Tebartz van Elst
Journal:  Dtsch Arztebl Int       Date:  2008-04-25       Impact factor: 5.594

6.  [Attention deficit hyperactivity syndrome throughout the life span].

Authors:  K Konrad; M Rösler
Journal:  Nervenarzt       Date:  2009-11       Impact factor: 1.214

7.  [Pediatric ADHD: what does the otolaryngologist need to know?].

Authors:  J Gehrmann; A Brandl
Journal:  HNO       Date:  2013-07       Impact factor: 1.284

Review 8.  [Minimal cerebral dysfunctions and ADHD in adulthood].

Authors:  M Linden; J Weddigen
Journal:  Nervenarzt       Date:  2016-11       Impact factor: 1.214

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.